GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00310323 | Colorectum | FAP | actomyosin structure organization | 51/2622 | 196/18723 | 5.89e-06 | 1.88e-04 | 51 |
GO:00507672 | Colorectum | FAP | regulation of neurogenesis | 82/2622 | 364/18723 | 6.28e-06 | 1.96e-04 | 82 |
GO:19033124 | Colorectum | FAP | negative regulation of mRNA metabolic process | 29/2622 | 92/18723 | 1.31e-05 | 3.53e-04 | 29 |
GO:00458624 | Colorectum | FAP | positive regulation of proteolysis | 81/2622 | 372/18723 | 2.64e-05 | 6.08e-04 | 81 |
GO:00322313 | Colorectum | FAP | regulation of actin filament bundle assembly | 30/2622 | 105/18723 | 7.54e-05 | 1.37e-03 | 30 |
GO:00069843 | Colorectum | FAP | ER-nucleus signaling pathway | 17/2622 | 46/18723 | 8.85e-05 | 1.57e-03 | 17 |
GO:00300383 | Colorectum | FAP | contractile actin filament bundle assembly | 30/2622 | 106/18723 | 9.12e-05 | 1.59e-03 | 30 |
GO:00431493 | Colorectum | FAP | stress fiber assembly | 30/2622 | 106/18723 | 9.12e-05 | 1.59e-03 | 30 |
GO:00431222 | Colorectum | FAP | regulation of I-kappaB kinase/NF-kappaB signaling | 56/2622 | 249/18723 | 1.82e-04 | 2.69e-03 | 56 |
GO:01100203 | Colorectum | FAP | regulation of actomyosin structure organization | 28/2622 | 100/18723 | 1.88e-04 | 2.76e-03 | 28 |
GO:00519601 | Colorectum | FAP | regulation of nervous system development | 89/2622 | 443/18723 | 2.32e-04 | 3.25e-03 | 89 |
GO:20012334 | Colorectum | FAP | regulation of apoptotic signaling pathway | 74/2622 | 356/18723 | 2.65e-04 | 3.60e-03 | 74 |
GO:00331194 | Colorectum | FAP | negative regulation of RNA splicing | 11/2622 | 25/18723 | 2.66e-04 | 3.61e-03 | 11 |
GO:00518652 | Colorectum | FAP | protein autoubiquitination | 22/2622 | 73/18723 | 2.88e-04 | 3.77e-03 | 22 |
GO:00226134 | Colorectum | FAP | ribonucleoprotein complex biogenesis | 91/2622 | 463/18723 | 4.28e-04 | 5.12e-03 | 91 |
GO:00614583 | Colorectum | FAP | reproductive system development | 85/2622 | 427/18723 | 4.30e-04 | 5.13e-03 | 85 |
GO:00486083 | Colorectum | FAP | reproductive structure development | 84/2622 | 424/18723 | 5.40e-04 | 6.10e-03 | 84 |
GO:00514922 | Colorectum | FAP | regulation of stress fiber assembly | 25/2622 | 91/18723 | 5.55e-04 | 6.22e-03 | 25 |
GO:00108213 | Colorectum | FAP | regulation of mitochondrion organization | 35/2622 | 144/18723 | 6.44e-04 | 7.05e-03 | 35 |
GO:00431232 | Colorectum | FAP | positive regulation of I-kappaB kinase/NF-kappaB signaling | 42/2622 | 186/18723 | 1.01e-03 | 9.89e-03 | 42 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
F10 | SNV | Missense_Mutation | novel | c.260N>T | p.Gly87Val | p.G87V | P00742 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-A2-A25A-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Cytoxan | SD |
F10 | SNV | Missense_Mutation | novel | c.240N>A | p.Phe80Leu | p.F80L | P00742 | protein_coding | deleterious(0) | probably_damaging(0.927) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
F10 | SNV | Missense_Mutation | rs121964941 | c.1120T>C | p.Ser374Pro | p.S374P | P00742 | protein_coding | deleterious(0.03) | possibly_damaging(0.511) | TCGA-AO-A128-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
F10 | SNV | Missense_Mutation | | c.8N>A | p.Arg3His | p.R3H | P00742 | protein_coding | tolerated_low_confidence(0.16) | benign(0) | TCGA-BH-A18G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
F10 | SNV | Missense_Mutation | | c.860N>T | p.Arg287Met | p.R287M | P00742 | protein_coding | tolerated(0.11) | probably_damaging(0.95) | TCGA-BH-A18G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
F10 | insertion | Frame_Shift_Ins | novel | c.950_951insCAGCCTGTTGAGGTTTGCGATTCTTGTTTCCTGGTTCGAGTCTT | p.Glu317AspfsTer16 | p.E317Dfs*16 | P00742 | protein_coding | | | TCGA-A2-A04Q-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
F10 | insertion | In_Frame_Ins | novel | c.958_959insGGCCTC | p.Asp320delinsGlyProHis | p.D320delinsGPH | P00742 | protein_coding | | | TCGA-BH-A0E2-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
F10 | insertion | Nonsense_Mutation | novel | c.959_960insTCTGCATCTTTAGGAAGAATGGTTGGTGTTCGTGT | p.Phe321LeufsTer4 | p.F321Lfs*4 | P00742 | protein_coding | | | TCGA-BH-A0E2-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
F10 | insertion | Nonsense_Mutation | novel | c.987_988insTATACATTTTAAAATATAAA | p.Thr330TyrfsTer4 | p.T330Yfs*4 | P00742 | protein_coding | | | TCGA-E9-A1NC-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | CR |
F10 | SNV | Missense_Mutation | rs201675411 | c.1016C>T | p.Ala339Val | p.A339V | P00742 | protein_coding | tolerated(1) | benign(0.147) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
2159 | F10 | DRUGGABLE GENOME, PROTEASE, ENZYME | | Apixaban | APIXABAN | |
2159 | F10 | DRUGGABLE GENOME, PROTEASE, ENZYME | | BIBT986 | TANOGITRAN | |
2159 | F10 | DRUGGABLE GENOME, PROTEASE, ENZYME | | Trimidox | TRIMETHOPRIM/SULFADOXINE | |
2159 | F10 | DRUGGABLE GENOME, PROTEASE, ENZYME | | Emicizumab | EMICIZUMAB | |
2159 | F10 | DRUGGABLE GENOME, PROTEASE, ENZYME | | PRT4445 | | |
2159 | F10 | DRUGGABLE GENOME, PROTEASE, ENZYME | inhibitor | 405067325 | OTAMIXABAN | |
2159 | F10 | DRUGGABLE GENOME, PROTEASE, ENZYME | | SR-123781A | | |
2159 | F10 | DRUGGABLE GENOME, PROTEASE, ENZYME | inhibitor | CHEMBL1908371 | IDRAPARINUX SODIUM | |
2159 | F10 | DRUGGABLE GENOME, PROTEASE, ENZYME | | FACTOR IX | | |
2159 | F10 | DRUGGABLE GENOME, PROTEASE, ENZYME | | ANTITHROMBIN | | |